Antibody validation – who has the best approach?
Here at CiteAb, we eat, live and breath antibodies every day, so making sure that scientists can easily find those that will work in their research is core to our organisation.
We’ve been thrilled to see a number of exciting initiatives in antibody validation start over the past few years, and this award looks to highlight these efforts and recognise best practice.
However, some organisations are really going above and beyond, so in this year’s CiteAb Antibody Awards we’ve included a category to highlight these, and to show off best-practice.
The ‘Most exciting antibody validation initiative’ category is sponsored by F1000Research. We spoke to Michael Markie, Associate Publisher at F1000Research, about what antibody validation means to F1000, and why they were keen to be involved in this category.
Michael said: “Reliable antibody validation will help make future research publications more replicable and reliable. A way to achieve this is if industry and academia work together to provide detailed information on antibody validations.
“Through an open science approach of documenting detailed protocols, robust methodologies and full datasets of validations the scientific community as whole will benefit and valuable time and resources can be spared. It will be easier for researchers to find reliable antibody information and easier for manufacturers to gain the trust of their customers when validation efforts are openly and publicly shared.”
This award is open for self or third-party nomination, so if you’re working with a company that has a great initiative, or if you’ve been influenced by one you’ve come across, please do make your nomination today!
To find out more about this category and to make your nomination, click here.
To learn more about CiteAb Antibody Awards, click here.
Categories close to nominations at 23:59 (GMT) on Friday 22nd January.
– Katrina and the CiteAb team
